In conclusion, we characterized the expression feature of miR-29a/miR-29b and their target genes Mcl-1 and Bcl-2 in Chinese AML and CML patients. This evidence concerns the gene BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive.